Here are six key notes on major spine and orthopedic device companies. NuVasive released its preliminary unaudited financial results this week for the full year of 2013 and anticipates earning $683 million in revenue.
Carlyle Group, a private equity firm, agreed to purchase Johnson & Johnson's ortho-clinical testing business for $4.15 billion.
Aurora Spine completed its private placement of common shares, and the offering is for 3,173,936 common shares at a price of $3.15 per share, which would bring $9,997,898.40 in gross proceeds.
Akron, Ohio-based Intellirod Spine was awarded $1.6 million in debt financing from Ohio Third Frontier's Commercial Acceleration Loan Fund.
Titan Spine received five new patents from the U.S. Patent and Trademark Office relating to its Endoskeleton interbody devices.
Boston-based Tegra Medical named J. Mark King, former chief operating officer, as its new chief executive officer.
More Articles on Spine:
Boutique Spine Practices: An Answer to Healthcare Reform?
5 Spine & Neurosurgeons in New Leadership Positions
Dr. Yaron Moshel Joins Atlantic NeuroSurgical Specialists